Psychologists in Arkansas City, KS Accepting Medicare
2 Psychologists found. Showing 1 - 2
 Dr. Tricia Denise Thornburgh Blatchford, PSY.D. Psychologist - Cognitive & Behavioral Medicare: Medicare Enrolled Practice Location: 801 S Boyer Rd, Arkansas City, KS 67005 Phone: 620-660-2192 |
Amber Jennings Psychologist - Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1107 N 11th St, Arkansas City, KS 67005 Phone: 620-660-2560 |
News Archive
NSW selects ZOLL AED Plus devices for Rural Fire Service stations
ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that it has received an award from the Government of NSW Australia to provide 5450 AED Plus devices for installation on all Rural Fire Service stations deployed throughout the State of New South Wales.
New form of immunotherapy increases survival in children with neuroblastoma
Administering a new form of immunotherapy to children with neuroblastoma, a nervous system cancer, increased the percentage of those who were alive and free of disease progression after two years, according to researchers at the University of California, San Diego School of Medicine and fellow institutions. The percentage rose from 46 percent for children receiving a standard therapy to 66 percent for children receiving immunotherapy plus standard therapy, according to the study published in the Sept. 30, 2010 issue of the New England Journal of Medicine.
Collagen deficiency in mice causes premature development of osteoarthritis and degenerative disc disease
Osteoarthritis (OA) and degenerative disc disease (DDD) are common, chronic musculoskeletal disorders. Both diseases cause joint pain, loss of function, and decreased quality of life for the more than 27 million OA and 59 million DDD suffers in the US. According to a 2003 Medical Expenditure Panel Survey, arthritis such as OA costs the U.S. economy nearly $128 billion per year in medical care and indirect expenses including lost wages and productivity.
TB Alliance launches three-drug combination trial for drug-sensitive and multidrug-resistant TB
In advance of the 41st Union World Conference, the Global Alliance for TB Drug Development (TB Alliance) today announced the launch of the first clinical trial to test a novel tuberculosis regimen in a new development paradigm designed to speed new treatments to patients. This novel three-drug combination shows promise to treat both drug-sensitive (DS-TB) and multidrug-resistant TB (MDR-TB), and alter the course of the TB pandemic by shortening and simplifying treatment worldwide.
Dual therapy improves cardiac outcomes in pediatric patients suffering from MIS-C
A recent study by a multidisciplinary team of cardiologists and infectious disease specialists at Children's Hospital Colorado (Children's Colorado) found that pediatric patients suffering from Multisystem Inflammatory Syndrome (MIS-C) who received initial, intensified therapy consisting of intravenous immunoglobulin (IVIG) plus Infliximab had improved cardiac outcomes versus those who received IVIG alone.
› Verified 3 days ago